Essential Reads: More Data on ADHD Medications and Pregnancy
Women with attention-deficit/hyperactivity disorder (ADHD) often discontinue psychostimulant medications during pregnancy, especially if they have milder symptoms. While this approach makes sense in terms of limiting unnecessary exposures in women with what appears to be milder illness, we have often been surprised by clinical outcomes in this population, specifically when women who were previously high functioning experience significant psychiatric morbidity during pregnancy after discontinuation of stimulants. Supporting these clinical observations [...]
Taking a Closer Look at Motor Development in Children with Prenatal Exposure to Antidepressants
While we have data to support the use of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs) and the serotonin norepinephrine reuptake inhibitors (SNRIs), during pregnancy, most studies have focused on risk of congenital malformations, and we have considerably less information on longer term neurodevelopmental outcomes. A new study from Galbally and colleagues was designed to determine whether prenatal exposure to antidepressants affects motor development across two domains: sensorimotor development [...]
Weekly Roundup for JANUARY 15, 2021: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and menopausal mental health. Galbally and colleagues look at the motor development of children exposed to antidepressants in utero. The findings of this study demonstrate an inconsistent pattern of associations with prenatal antidepressant exposure across the neuropsychological [...]
Essential Reads: Is there a Role for Omega-3 Fatty Acids in Women at Risk for Perinatal Depression?
The omega-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential components of the human diet and have a broad range of health benefits. Furthermore, they may also be beneficial for the treatment of mood disorders. Outside of the perinatal period, several studies have demonstrated that omega-3 PUFA supplementation may have antidepressant effects in patients with major depression. The greatest benefit has been observed in studies [...]
Postpartum Depression: Unipolar or Bipolar?
About 15% of women will experience postpartum depression after the birth of a child. While most of those women will have unipolar depression, a certain number of women will have bipolar depression. At this juncture, making the correct diagnosis is vital, as the treatment of bipolar depression differs from the treatments typically used for unipolar depression is this setting. Furthermore, the use of antidepressants in a woman with bipolar disorder may [...]
Weekly Roundup for JANUARY 8, 2021: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and menopausal mental health. Welcome to the first weekly roundup of 2021, and there are more new articles than ever. While historically we have seen many articles investigating the impact of prenatal exposure to antidepressants on children's [...]